Gestational Exposure to Benzodiazepines and Z-Hypnotics and the Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring
The Journal of Clinical Psychiatry · 2023
DOI: 10.4088/jcp.23f14863 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, 2023. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (candrade@psyc…. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Autism Spectrum Disorder, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (candrade@psychiatrist.com).
Zitieren
APA
Andrade, C. (2023). Gestational Exposure to Benzodiazepines and Z-Hypnotics and the Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.23f14863
Vancouver
Andrade C. Gestational Exposure to Benzodiazepines and Z-Hypnotics and the Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring. The Journal of Clinical Psychiatry. 2023. doi:10.4088/jcp.23f14863
BibTeX
@article{Andrade2023,
author = {Andrade, Chittaranjan},
title = {Gestational Exposure to Benzodiazepines and Z-Hypnotics and the Risk of Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring},
journal = {The Journal of Clinical Psychiatry},
year = {2023},
doi = {10.4088/jcp.23f14863}
}
EUVIMED